Phase 3 study of cetirizine dry syrup in children suffering from atopic dermatitis.
Phase 3
- Conditions
- Atopic dermatitis
- Registration Number
- JPRN-jRCT2080220120
- Lead Sponsor
- GlaxoSmithKline K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Not specified
- Target Recruitment
- 278
Inclusion Criteria
Age: 3 to 14, Children with atopic dermatitis, patients eligible for evaluation of pruitus, etc.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the severity of pruritus, safety etc.
- Secondary Outcome Measures
Name Time Method